Related Experiment Video

Updated: May 13, 2026

Cultivating Ex Vivo Patient-Derived Glioma Organoids Using a Tissue Chopper
05:45

Cultivating Ex Vivo Patient-Derived Glioma Organoids Using a Tissue Chopper

Published on: January 19, 2024

'Elderly' patients with newly diagnosed glioblastoma deserve optimal care

Matthias Holdhoff, Gary L Rosner, Sara Alcorn

    Journal of Neuro-Oncology
    |March 26, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
    06:15

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

    Published on: October 27, 2014

    Related Experiment Videos

    Last Updated: May 13, 2026

    Cultivating Ex Vivo Patient-Derived Glioma Organoids Using a Tissue Chopper
    05:45

    Cultivating Ex Vivo Patient-Derived Glioma Organoids Using a Tissue Chopper

    Published on: January 19, 2024

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
    06:15

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

    Published on: October 27, 2014

    Related Concept Videos

    Alzheimer's Disease: Treatment01:22

    Alzheimer's Disease: Treatment

    Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

    Articles linked to this work by shared authors, journal, and citation graph.

    Pitfalls in 2HG Detection With TE-Optimized MRS at 3T.

    Journal of neuroimaging : official journal of the American Society of Neuroimaging·2026

    A novel approach to reverse Warburg metabolism in patients with recurrent glioblastoma: A phase II pharmacodynamic study of dichloroacetate.

    Neuro-oncology advances·2026

    ALT phenotype assessment in IDH-mutant astrocytoma supports biologic consequence of ATRX missense mutations.

    Brain pathology (Zurich, Switzerland)·2026

    Commensurate prior models with random effects for interval-censored data to accommodate historical controls.

    Communications in statistics: Simulation and computation·2026

    Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.

    Nature medicine·2026

    BRAF-altered glioma in adults and children: A Society for Neuro-Oncology (SNO) and European Society for Neuro-Oncology (EANO) consensus review on clinical management and future directions.

    Neuro-oncology·2026

    Brain dose burden is associated with treatment-related lymphopenia in IDH-wildtype glioblastoma: dosimetric determinants and prognostic impact.

    Journal of neuro-oncology·2026

    CD73 and PD-L1 expression in WHO grade 1 and grade 2 meningiomas: an exploratory analysis of purinergic and immune-related profiles.

    Journal of neuro-oncology·2026

    Long-term outcomes after adjuvant radiotherapy in adult spinal ependymomas: a multicenter study by the trod Neuro-Oncology research group (07 - 005).

    Journal of neuro-oncology·2026

    Meningiomas classified as grade 2 due to brain invasion alone have better progression-free survival than other atypical meningiomas.

    Journal of neuro-oncology·2026

    Prognostic significance of walking ability at hospital discharge for overall survival in newly diagnosed glioblastoma: a comparison across six peri-treatment assessments.

    Journal of neuro-oncology·2026

    Assessing the personal financial impact of vestibular schwannoma management.

    Journal of neuro-oncology·2026

    Evidence for a tubular basement membrane-cilia connection in autosomal dominant polycystic kidney disease pathogenesis.

    The Journal of clinical investigation·2026

    Dietary bioactive compounds modulate intestinal stem cells to alleviate colorectal lesions.

    Critical reviews in food science and nutrition·2026

    Li-Fraumeni Syndrome: Current Perspectives on Molecular Pathogenesis, Surveillance Strategies, Clinical Management and Pediatric Considerations.

    Cureus·2026

    GLP-1 Receptor Agonist and GIP/GLP-1 Receptor Dual Agonist Therapeutics at the Intersection of Alcohol Use Disorder, Obesity, and Cardiometabolic Dysfunction.

    Biological psychiatry global open science·2026

    Molecular diagnostics in paediatric oncology in Latin America: findings from the Latin America Regional Advisory Committee (RAC LATAM) regional assessment.

    Ecancermedicalscience·2026

    Fecal microbiota and metabolite profiles in patients with osteoarthritis: a cross-sectional study.

    Frontiers in cellular and infection microbiology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us